Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-06-06
1997-04-29
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 14, C07D27936, A61K 3154
Patent
active
056249241
ABSTRACT:
Quinobenzothiazine derivatives of the formula ##STR1## as well as the pharmaceutically acceptable salts, esters, amides and prodrugs thereof are disclosed, wherein R.sup.1 is hydrogen or acarboxy-protecting group, R.sup.2 and R.sup.3 are substitutents, A is oxygen, sulfur, or carbon, Z is a halogen or a nitrogen-containing group, X is hydrogen, halogen or alkyl, and W is hydrogen, alkyl, amino or halogen. The compounds have potent antineoplastic activity.
REFERENCES:
patent: 4529725 (1985-07-01), Chu
patent: 4533663 (1985-08-01), Chu
Chu, Chemical Abstracts, vol. 104, entry 148892 (1985).
Chu, Chemical Abstracts, vol. 104, entry 198598 (1985).
Chu, Chemical Abstracts, vol. 104, entry 5885 (1985).
Chu Daniel T.
Hallas Robert
Plattner Jacob J.
Abbott Laboratories
Anand Mona
Ford John M.
LandOfFree
Quinobenzothiazine antineoplastic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinobenzothiazine antineoplastic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinobenzothiazine antineoplastic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-705852